NYSE$UNH
UnitedHealth · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
UnitedHealth Group's Q2 2024 performance reflected growth in revenues and earnings, but was impacted by cyberattack related costs and classification of South American operations as held for sale.
UnitedHealth Group reported Q2 2024 results with revenues of $98.9 billion, a $6 billion year-over-year increase led by Optum. Reported earnings were $4.54 per share, while adjusted earnings were $6.80 per share, including $0.28 in business disruption impacts. The company updated its full year 2024 net earnings outlook to $15.95 to $16.40 per share.
- Revenues grew nearly $6 billion year-over-year to $98.9 billion, led by Optum.
- Consumers served by UnitedHealthcare's commercial domestic offerings grew by 2.3 million year-to-date.
- Cash flows from operations were $6.7 billion, 1.5 times net income.
- Adjusted earnings of $6.80 per share include $0.28 in business disruption impacts and exclude South American and direct response costs.
Headline financials
Revenue & EPS history
UnitedHealth · Revenue · Quarterly
$98.9B
Revenue by segment
UnitedHealth · $92.4B total across 4 segments · Q3 2023
- Premiums$72.3B+12.2%78.3%
- Products$10.4B+12.7%11.2%
- Services$8.67B+29.4%9.4%
- Investment & Other$997M+94.3%1.1%
Forward guidance
The company updated its full year 2024 net earnings outlook to $15.95 to $16.40 per share to reflect the classification to held for sale of its remaining South America operations and the estimated Change Healthcare cyberattack impacts. The company affirmed the adjusted net earnings outlook of $27.50 to $28.00 per share established at its November 2023 Investor Conference.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+0.9%
Avg return
Earnings day
+1.3%
Avg return
5 days after
+2.6%
Avg return
30 days after
63%
46 / 73 earnings
Positive
+11.2%
Q2 2024
Best reaction
-22.4%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +9.7% | +18.1% | |
| Q4 2025 | -11.2% | -18.4% | -18.5% | |
| Q3 2025 | +0.1% | -6.7% | -9.9% | |
| Q2 2025 | +0.6% | +21.2% | +38.2% | |
| Q1 2025 | -22.4% | -27.0% | -50.1% | |
| Q4 2024 | -6.2% | -3.4% | -3.7% | |
| Q3 2024 | -5.6% | -5.9% | -2.0% | |
| Q2 2024 | +11.2% | +9.7% | +12.5% | |
| Q1 2024 | +7.5% | +12.5% | +17.0% | |
| Q4 2023 | -3.8% | -2.7% | -4.0% | |
| Q3 2023 | +2.4% | +2.0% | +3.0% | |
| Q2 2023 | +8.1% | +12.5% | +13.5% | |
| Q1 2023 | -4.0% | -7.6% | -6.7% | |
| Q4 2022 | -2.1% | -3.9% | -0.3% | |
| Q3 2022 | +2.3% | +2.0% | +2.4% | |
| Q2 2022 | +3.4% | +3.4% | +8.2% | |
| Q1 2022 | -0.5% | +0.1% | -9.6% | |
| Q4 2021 | +0.4% | +0.3% | +1.5% | |
| Q3 2021 | +6.1% | +5.2% | +13.7% | |
| Q2 2021 | +1.2% | -0.4% | -1.2% | |
| Q1 2021 | +4.1% | +5.6% | +9.1% | |
| Q4 2020 | +0.8% | -1.2% | -7.8% | |
| Q3 2020 | -2.1% | -2.2% | +7.3% | |
| Q2 2020 | -0.4% | -1.6% | +4.9% | |
| Q1 2020 | +10.3% | +4.3% | +7.6% | |
| Q4 2019 | +4.3% | +3.5% | +3.7% | |
| Q3 2019 | +7.4% | +11.2% | +16.0% | |
| Q2 2019 | -3.8% | -4.4% | -7.9% | |
| Q1 2019 | -5.8% | -3.7% | +2.9% | |
| Q4 2018 | +5.4% | +7.0% | +7.0% | |
| Q3 2018 | +2.7% | +1.9% | +1.8% | |
| Q2 2018 | -0.6% | -1.7% | +2.4% | |
| Q1 2018 | +2.6% | +2.1% | +5.5% | |
| Q4 2017 | +4.3% | +6.4% | -1.1% | |
| Q3 2017 | +6.2% | +7.4% | +9.3% | |
| Q2 2017 | +1.5% | +2.9% | +3.4% | |
| Q1 2017 | +1.2% | +2.4% | +2.6% | |
| Q4 2016 | -2.5% | -1.9% | +1.1% | |
| Q3 2016 | +7.6% | +8.4% | +12.4% | |
| Q2 2016 | +1.6% | +2.1% | +1.0% | |
| Q1 2016 | +4.8% | — | — | |
| Q4 2015 | +5.1% | — | — | |
| Q3 2015 | -1.7% | — | — | |
| Q2 2015 | -1.6% | — | — | |
| Q1 2015 | +1.2% | — | — | |
| Q4 2014 | +7.8% | — | — | |
| Q3 2014 | +7.3% | — | — | |
| Q2 2014 | +2.1% | — | — | |
| Q1 2014 | -4.1% | — | — | |
| Q4 2013 | -3.1% | — | — | |
| Q3 2013 | -8.6% | — | — | |
| Q2 2013 | +7.9% | — | — | |
| Q1 2013 | -3.2% | — | — | |
| Q4 2012 | +1.7% | — | — | |
| Q3 2012 | -2.6% | — | — | |
| Q2 2012 | -1.7% | — | — | |
| Q1 2012 | +3.8% | — | — | |
| Q4 2011 | +2.3% | — | — | |
| Q3 2011 | -2.2% | — | — | |
| Q2 2011 | -1.7% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | +0.7% | — | — | |
| Q3 2010 | -0.5% | — | — | |
| Q2 2010 | +1.6% | — | — | |
| Q1 2009 | -0.8% | — | — | |
| Q1 2010 | -0.2% | — | — | |
| Q4 2009 | +0.4% | — | — | |
| Q4 2007 | +0.4% | — | — | |
| Q3 2008 | +5.5% | — | — | |
| Q3 2009 | +5.5% | — | — | |
| Q4 2008 | +1.3% | — | — | |
| Q2 2008 | +1.3% | — | — | |
| Q2 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro